Device Trial Radar · NCT07485244
EEG Abnormalities in Adult ICU Patients With High Risk of Delirium
Last checked: Nov 19, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Apr 16, 2026
Primary completion
Dec 31, 2026
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Ceribell Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Vanderbilt University Medical Center
- First posted
- Mar 20, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium
Conditions
- Delirium in the Intensive Care Unit
Interventions
Ceribell EEG SystemDevice
EEG will be recorded with the Ceribell EEG System, including headband and recorder.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevalence of EEG Abnormalities on the Ceribell EEG SystemTime frame: Starting baseline through study completion, up to 1 year.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.